Osteoanabolic Estrogen Therapy in a Transsexual Man

    March 2008 in “ Deutsche medizinische Wochenschrift/Deutsche Medizinische Wochenschrift ”
    Th. Hierl, I. Börcsök, Rosemarie Ziegler, Christian Kasperk
    TLDR Adding estrogen increased bone mass in a transsexual man undergoing hormone therapy.
    A 31-year-old transsexual male undergoing male-to-female transition experienced significant changes in bone mass during hormone therapy. Initially treated with cyproterone acetate (100 mg/day) for 30 months, his bone mass decreased by 5% per year, leading to high turnover osteoporosis. However, after adding oral oestradiol valerate (2 mg/day), his bone mass increased by 4% per year. This study highlighted the crucial role of sex hormones, including oestrogens, in maintaining bone mass in males, demonstrating their anabolic effects on bone.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 120 results

    Similar Research

    5 / 1000+ results

      research Endocrine Intervention for Transsexuals

      88 citations , September 2003 in “Clinical endocrinology”
      Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.
      Progestogens in Menopausal Hormone Therapy

      research Progestogens in Menopausal Hormone Therapy

      10 citations , January 2015 in “Przeglad Menopauzalny”
      Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.
      Estrogens and the Skin

      research Estrogens and the Skin

      137 citations , June 2005 in “Climacteric”
      Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.